Background Antifungal prophylaxis is a promising strategy for reducing invasive fungal
infections (IFIs) in allogeneic hematopoietic cell transplant (alloHCT) recipients, but the …

In medical mycology, the main context of disease is iatrogenic-based disease. However,
historically, and occasionally, even today, fungal diseases affect humans with no obvious …

Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Importance Several antifungal drugs are available for antifungal prophylaxis in patients with
hematological disease or who are undergoing hematopoietic stem cell transplantation …

The patient has achieved a morphologic complete remission with 2 cycles of induction
chemotherapy. An HLA-matched unrelated donor has been identified, and he is planned to …

Clin Microbiol Infect 2011; 17 (Suppl. 2): 1–24 Abstract Invasive fungal infections (IFIs)
caused by filamentous fungi still have high rates of mortality, associated with difficulties in …

Objectives: The optimum trough concentration of itraconazole for clinical response and safty
is controversial. The objective of this systematic review and meta-analysis was to determine …

Several new antifungal agents have become available for primary fungal prophylaxis of
neutropenia fever in hematological malignancy patients. Our aim was to synthesize all …

Introduction: Invasive fungal infection (IFI) is a serious problem due to difficulties in early
diagnosis and high mortality. Different approaches are adopted for the treatment and …